nodes	percent_of_prediction	percent_of_DWPC	metapath
Mebendazole—CYP1A1—polycystic ovary syndrome	0.827	1	CbGaD
Mebendazole—TUBA1A—embryo—polycystic ovary syndrome	0.00647	0.0683	CbGeAlD
Mebendazole—CYP3A4—urine—polycystic ovary syndrome	0.00548	0.0578	CbGeAlD
Mebendazole—TUBA1A—adrenal cortex—polycystic ovary syndrome	0.0053	0.0559	CbGeAlD
Mebendazole—TUBA1A—endometrium—polycystic ovary syndrome	0.00473	0.05	CbGeAlD
Mebendazole—TUBA1A—uterus—polycystic ovary syndrome	0.00436	0.046	CbGeAlD
Mebendazole—TUBB4B—embryo—polycystic ovary syndrome	0.00431	0.0455	CbGeAlD
Mebendazole—TUBA1A—pituitary gland—polycystic ovary syndrome	0.00428	0.0452	CbGeAlD
Mebendazole—TUBA1A—adipose tissue—polycystic ovary syndrome	0.00426	0.045	CbGeAlD
Mebendazole—TUBA1A—adrenal gland—polycystic ovary syndrome	0.00383	0.0404	CbGeAlD
Mebendazole—Bopindolol—ADRB3—polycystic ovary syndrome	0.00378	0.482	CrCbGaD
Mebendazole—TUBA1A—female gonad—polycystic ovary syndrome	0.00357	0.0377	CbGeAlD
Mebendazole—TUBA1A—vagina—polycystic ovary syndrome	0.00355	0.0374	CbGeAlD
Mebendazole—TUBB4B—adrenal cortex—polycystic ovary syndrome	0.00353	0.0373	CbGeAlD
Mebendazole—TUBA1A—endocrine gland—polycystic ovary syndrome	0.00332	0.035	CbGeAlD
Mebendazole—TUBB4B—endometrium—polycystic ovary syndrome	0.00315	0.0333	CbGeAlD
Mebendazole—TUBB4B—uterus—polycystic ovary syndrome	0.00291	0.0307	CbGeAlD
Mebendazole—TUBB4B—pituitary gland—polycystic ovary syndrome	0.00285	0.0301	CbGeAlD
Mebendazole—TUBB4B—adipose tissue—polycystic ovary syndrome	0.00284	0.03	CbGeAlD
Mebendazole—Albendazole—CYP1A1—polycystic ovary syndrome	0.00263	0.335	CrCbGaD
Mebendazole—TUBB4B—adrenal gland—polycystic ovary syndrome	0.00255	0.0269	CbGeAlD
Mebendazole—TUBB4B—female gonad—polycystic ovary syndrome	0.00238	0.0251	CbGeAlD
Mebendazole—TUBB4B—vagina—polycystic ovary syndrome	0.00236	0.0249	CbGeAlD
Mebendazole—TUBB4B—endocrine gland—polycystic ovary syndrome	0.00221	0.0233	CbGeAlD
Mebendazole—CYP1A1—uterus—polycystic ovary syndrome	0.00163	0.0172	CbGeAlD
Mebendazole—CYP1A1—adipose tissue—polycystic ovary syndrome	0.00159	0.0168	CbGeAlD
Mebendazole—Bopindolol—ADRB2—polycystic ovary syndrome	0.00144	0.183	CrCbGaD
Mebendazole—CYP1A1—female gonad—polycystic ovary syndrome	0.00133	0.0141	CbGeAlD
Mebendazole—CYP1A1—vagina—polycystic ovary syndrome	0.00132	0.014	CbGeAlD
Mebendazole—ABCB1—embryo—polycystic ovary syndrome	0.00125	0.0132	CbGeAlD
Mebendazole—CYP1A1—endocrine gland—polycystic ovary syndrome	0.00124	0.0131	CbGeAlD
Mebendazole—ABCB1—adrenal cortex—polycystic ovary syndrome	0.00103	0.0108	CbGeAlD
Mebendazole—ABCB1—endometrium—polycystic ovary syndrome	0.000917	0.00968	CbGeAlD
Mebendazole—CYP3A4—endocrine gland—polycystic ovary syndrome	0.000908	0.00959	CbGeAlD
Mebendazole—ABCB1—uterus—polycystic ovary syndrome	0.000845	0.00892	CbGeAlD
Mebendazole—ABCB1—pituitary gland—polycystic ovary syndrome	0.00083	0.00876	CbGeAlD
Mebendazole—ABCB1—adipose tissue—polycystic ovary syndrome	0.000827	0.00873	CbGeAlD
Mebendazole—ABCB1—adrenal gland—polycystic ovary syndrome	0.000741	0.00783	CbGeAlD
Mebendazole—ABCB1—female gonad—polycystic ovary syndrome	0.000691	0.0073	CbGeAlD
Mebendazole—ABCB1—vagina—polycystic ovary syndrome	0.000687	0.00725	CbGeAlD
Mebendazole—ABCB1—endocrine gland—polycystic ovary syndrome	0.000643	0.00679	CbGeAlD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—MAD2L1—polycystic ovary syndrome	0.000313	0.00445	CbGpPWpGaD
Mebendazole—ABCB1—HIF-1-alpha transcription factor network—IGFBP1—polycystic ovary syndrome	0.000311	0.00443	CbGpPWpGaD
Mebendazole—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—polycystic ovary syndrome	0.000305	0.00434	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—RRM2—polycystic ovary syndrome	0.000296	0.00421	CbGpPWpGaD
Mebendazole—CYP1A1—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.000294	0.00418	CbGpPWpGaD
Mebendazole—TUBA1A—Metabolism of proteins—LHB—polycystic ovary syndrome	0.000293	0.00416	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—LMNA—polycystic ovary syndrome	0.000291	0.00413	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—MAD2L1—polycystic ovary syndrome	0.00028	0.00398	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—TOP2A—polycystic ovary syndrome	0.000279	0.00396	CbGpPWpGaD
Mebendazole—CYP3A4—Estrogen metabolism—CYP1A1—polycystic ovary syndrome	0.000278	0.00395	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—BAX—polycystic ovary syndrome	0.000274	0.00389	CbGpPWpGaD
Mebendazole—CYP1A1—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.000274	0.00389	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—CCNE2—polycystic ovary syndrome	0.000273	0.00387	CbGpPWpGaD
Mebendazole—ABCB1—Allograft Rejection—FOXP3—polycystic ovary syndrome	0.000272	0.00387	CbGpPWpGaD
Mebendazole—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.000267	0.0038	CbGpPWpGaD
Mebendazole—CYP1A1—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.000264	0.00375	CbGpPWpGaD
Mebendazole—TUBA1A—Metabolism of proteins—IGFBP1—polycystic ovary syndrome	0.000262	0.00372	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—LMNA—polycystic ovary syndrome	0.00026	0.0037	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—CDC6—polycystic ovary syndrome	0.000256	0.00364	CbGpPWpGaD
Mebendazole—CYP3A4—Xenobiotics—CYP1A1—polycystic ovary syndrome	0.000255	0.00363	CbGpPWpGaD
Mebendazole—CYP1A1—PPARA activates gene expression—SULT2A1—polycystic ovary syndrome	0.000252	0.00359	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—CCNB1—polycystic ovary syndrome	0.000251	0.00357	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—TOP2A—polycystic ovary syndrome	0.000249	0.00354	CbGpPWpGaD
Mebendazole—ABCB1—HIF-1-alpha transcription factor network—TFRC—polycystic ovary syndrome	0.000247	0.00352	CbGpPWpGaD
Mebendazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—SULT2A1—polycystic ovary syndrome	0.000247	0.00351	CbGpPWpGaD
Mebendazole—CYP3A4—Tamoxifen metabolism—CYP1A1—polycystic ovary syndrome	0.000245	0.00349	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—CCNE2—polycystic ovary syndrome	0.000244	0.00346	CbGpPWpGaD
Mebendazole—TUBB4B—Metabolism of proteins—INHBB—polycystic ovary syndrome	0.000239	0.0034	CbGpPWpGaD
Mebendazole—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—polycystic ovary syndrome	0.000236	0.00335	CbGpPWpGaD
Mebendazole—CYP1A1—PPARA activates gene expression—YAP1—polycystic ovary syndrome	0.000236	0.00335	CbGpPWpGaD
Mebendazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—YAP1—polycystic ovary syndrome	0.000231	0.00328	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—CDC6—polycystic ovary syndrome	0.000229	0.00326	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—CCNB1—polycystic ovary syndrome	0.000224	0.00319	CbGpPWpGaD
Mebendazole—TUBA1A—Metabolism of proteins—LMNA—polycystic ovary syndrome	0.000217	0.00308	CbGpPWpGaD
Mebendazole—CYP1A1—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000217	0.00308	CbGpPWpGaD
Mebendazole—TUBB4B—Metabolism of proteins—RPL37A—polycystic ovary syndrome	0.000214	0.00305	CbGpPWpGaD
Mebendazole—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.000205	0.00291	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—RRM2—polycystic ovary syndrome	0.0002	0.00284	CbGpPWpGaD
Mebendazole—TUBA1A—Metabolism of proteins—GHRL—polycystic ovary syndrome	0.000193	0.00275	CbGpPWpGaD
Mebendazole—CYP1A1—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000189	0.00269	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—MAD2L1—polycystic ovary syndrome	0.000189	0.00269	CbGpPWpGaD
Mebendazole—TUBA1A—Metabolism of proteins—ACE—polycystic ovary syndrome	0.000187	0.00266	CbGpPWpGaD
Mebendazole—TUBA1A—Metabolism of proteins—TCF7L2—polycystic ovary syndrome	0.00018	0.00256	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—RRM2—polycystic ovary syndrome	0.000179	0.00254	CbGpPWpGaD
Mebendazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	0.000179	0.00254	CbGpPWpGaD
Mebendazole—TUBB4B—Metabolism of proteins—LHB—polycystic ovary syndrome	0.000177	0.00251	CbGpPWpGaD
Mebendazole—CYP1A1—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000177	0.00251	CbGpPWpGaD
Mebendazole—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.000176	0.00251	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—LMNA—polycystic ovary syndrome	0.000176	0.0025	CbGpPWpGaD
Mebendazole—CYP1A1—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000174	0.00247	CbGpPWpGaD
Mebendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—SULT2A1—polycystic ovary syndrome	0.00017	0.00242	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—MAD2L1—polycystic ovary syndrome	0.000169	0.0024	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—TOP2A—polycystic ovary syndrome	0.000168	0.00239	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.000167	0.00238	CbGpPWpGaD
Mebendazole—CYP3A4—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.000167	0.00238	CbGpPWpGaD
Mebendazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.000166	0.00236	CbGpPWpGaD
Mebendazole—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.000164	0.00233	CbGpPWpGaD
Mebendazole—CYP3A4—Tryptophan metabolism—CYP19A1—polycystic ovary syndrome	0.000163	0.00231	CbGpPWpGaD
Mebendazole—CYP1A1—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000161	0.00228	CbGpPWpGaD
Mebendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—YAP1—polycystic ovary syndrome	0.000159	0.00226	CbGpPWpGaD
Mebendazole—TUBB4B—Metabolism of proteins—IGFBP1—polycystic ovary syndrome	0.000158	0.00225	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—LMNA—polycystic ovary syndrome	0.000157	0.00223	CbGpPWpGaD
Mebendazole—CYP1A1—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000156	0.00222	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.000156	0.00222	CbGpPWpGaD
Mebendazole—CYP1A1—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000154	0.00219	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—FST—polycystic ovary syndrome	0.000152	0.00217	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—CCNB1—polycystic ovary syndrome	0.000152	0.00216	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—TOP2A—polycystic ovary syndrome	0.000151	0.00214	CbGpPWpGaD
Mebendazole—CYP1A1—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000146	0.00207	CbGpPWpGaD
Mebendazole—CYP1A1—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000145	0.00207	CbGpPWpGaD
Mebendazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.000145	0.00206	CbGpPWpGaD
Mebendazole—CYP1A1—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000143	0.00204	CbGpPWpGaD
Mebendazole—CYP1A1—PPARA activates gene expression—NCOR1—polycystic ovary syndrome	0.00014	0.00199	CbGpPWpGaD
Mebendazole—ABCB1—HIF-1-alpha transcription factor network—LEP—polycystic ovary syndrome	0.000138	0.00197	CbGpPWpGaD
Mebendazole—TUBB4B—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000138	0.00196	CbGpPWpGaD
Mebendazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—NCOR1—polycystic ovary syndrome	0.000137	0.00195	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—CCNB1—polycystic ovary syndrome	0.000136	0.00193	CbGpPWpGaD
Mebendazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.000135	0.00191	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.000132	0.00188	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.000132	0.00188	CbGpPWpGaD
Mebendazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.000131	0.00187	CbGpPWpGaD
Mebendazole—CYP3A4—Tryptophan metabolism—CYP1A1—polycystic ovary syndrome	0.000131	0.00186	CbGpPWpGaD
Mebendazole—TUBB4B—Metabolism of proteins—LMNA—polycystic ovary syndrome	0.000131	0.00186	CbGpPWpGaD
Mebendazole—CYP1A1—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.00013	0.00185	CbGpPWpGaD
Mebendazole—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.00013	0.00184	CbGpPWpGaD
Mebendazole—TUBB4B—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000128	0.00183	CbGpPWpGaD
Mebendazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.000126	0.00179	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—polycystic ovary syndrome	0.000125	0.00177	CbGpPWpGaD
Mebendazole—TUBB4B—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000117	0.00167	CbGpPWpGaD
Mebendazole—TUBB4B—Metabolism of proteins—GHRL—polycystic ovary syndrome	0.000117	0.00166	CbGpPWpGaD
Mebendazole—TUBA1A—Metabolism of proteins—LEP—polycystic ovary syndrome	0.000116	0.00165	CbGpPWpGaD
Mebendazole—CYP1A1—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000115	0.00164	CbGpPWpGaD
Mebendazole—CYP1A1—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000113	0.00161	CbGpPWpGaD
Mebendazole—TUBB4B—Metabolism of proteins—ACE—polycystic ovary syndrome	0.000113	0.00161	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.000111	0.00158	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000111	0.00158	CbGpPWpGaD
Mebendazole—TUBB4B—Metabolism of proteins—TCF7L2—polycystic ovary syndrome	0.000109	0.00154	CbGpPWpGaD
Mebendazole—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—polycystic ovary syndrome	0.000109	0.00154	CbGpPWpGaD
Mebendazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000107	0.00151	CbGpPWpGaD
Mebendazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000106	0.00151	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—polycystic ovary syndrome	0.000106	0.0015	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.000105	0.0015	CbGpPWpGaD
Mebendazole—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000105	0.00149	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.000101	0.00143	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.0001	0.00143	CbGpPWpGaD
Mebendazole—CYP1A1—PPARA activates gene expression—PPARG—polycystic ovary syndrome	0.0001	0.00142	CbGpPWpGaD
Mebendazole—TUBA1A—Metabolism of proteins—POMC—polycystic ovary syndrome	9.98e-05	0.00142	CbGpPWpGaD
Mebendazole—TUBA1A—Metabolism of proteins—INS—polycystic ovary syndrome	9.93e-05	0.00141	CbGpPWpGaD
Mebendazole—TUBB4B—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	9.85e-05	0.0014	CbGpPWpGaD
Mebendazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—polycystic ovary syndrome	9.81e-05	0.00139	CbGpPWpGaD
Mebendazole—TUBA1A—Metabolism of proteins—IGF1—polycystic ovary syndrome	9.6e-05	0.00137	CbGpPWpGaD
Mebendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—NCOR1—polycystic ovary syndrome	9.43e-05	0.00134	CbGpPWpGaD
Mebendazole—CYP3A4—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	9.31e-05	0.00132	CbGpPWpGaD
Mebendazole—CYP3A4—Biological oxidations—SULT2A1—polycystic ovary syndrome	8.69e-05	0.00123	CbGpPWpGaD
Mebendazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	8.59e-05	0.00122	CbGpPWpGaD
Mebendazole—CYP3A4—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	8.57e-05	0.00122	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	8.53e-05	0.00121	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—AR—polycystic ovary syndrome	8.22e-05	0.00117	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—NMNAT3—polycystic ovary syndrome	8.16e-05	0.00116	CbGpPWpGaD
Mebendazole—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	7.9e-05	0.00112	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	7.78e-05	0.00111	CbGpPWpGaD
Mebendazole—CYP3A4—Biological oxidations—CYP11A1—polycystic ovary syndrome	7.69e-05	0.00109	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	7.6e-05	0.00108	CbGpPWpGaD
Mebendazole—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	7.59e-05	0.00108	CbGpPWpGaD
Mebendazole—ABCB1—HIF-1-alpha transcription factor network—VEGFA—polycystic ovary syndrome	7.46e-05	0.00106	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—SUOX—polycystic ovary syndrome	7.46e-05	0.00106	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—LPCAT2—polycystic ovary syndrome	7.46e-05	0.00106	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	7.36e-05	0.00105	CbGpPWpGaD
Mebendazole—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	7.17e-05	0.00102	CbGpPWpGaD
Mebendazole—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	7.15e-05	0.00102	CbGpPWpGaD
Mebendazole—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	7.05e-05	0.001	CbGpPWpGaD
Mebendazole—TUBB4B—Metabolism of proteins—LEP—polycystic ovary syndrome	7.02e-05	0.000998	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	7e-05	0.000995	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—ISYNA1—polycystic ovary syndrome	6.93e-05	0.000986	CbGpPWpGaD
Mebendazole—CYP1A1—Biological oxidations—POMC—polycystic ovary syndrome	6.91e-05	0.000983	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	6.78e-05	0.000964	CbGpPWpGaD
Mebendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—polycystic ovary syndrome	6.76e-05	0.000961	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—NMNAT3—polycystic ovary syndrome	6.51e-05	0.000926	CbGpPWpGaD
Mebendazole—ABCB1—Allograft Rejection—VEGFA—polycystic ovary syndrome	6.46e-05	0.000919	CbGpPWpGaD
Mebendazole—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	6.4e-05	0.00091	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	6.33e-05	0.0009	CbGpPWpGaD
Mebendazole—TUBB4B—Metabolism of proteins—POMC—polycystic ovary syndrome	6.03e-05	0.000857	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	6e-05	0.000854	CbGpPWpGaD
Mebendazole—TUBB4B—Metabolism of proteins—INS—polycystic ovary syndrome	6e-05	0.000852	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—LPCAT2—polycystic ovary syndrome	5.96e-05	0.000847	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—SUOX—polycystic ovary syndrome	5.96e-05	0.000847	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—TEAD2—polycystic ovary syndrome	5.9e-05	0.000838	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—AKR1C2—polycystic ovary syndrome	5.9e-05	0.000838	CbGpPWpGaD
Mebendazole—TUBB4B—Metabolism of proteins—IGF1—polycystic ovary syndrome	5.8e-05	0.000824	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	5.67e-05	0.000806	CbGpPWpGaD
Mebendazole—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	5.66e-05	0.000805	CbGpPWpGaD
Mebendazole—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	5.58e-05	0.000794	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	5.58e-05	0.000793	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—ISYNA1—polycystic ovary syndrome	5.54e-05	0.000787	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PNPLA2—polycystic ovary syndrome	4.94e-05	0.000702	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	4.88e-05	0.000694	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—AKR1C2—polycystic ovary syndrome	4.71e-05	0.00067	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—TEAD2—polycystic ovary syndrome	4.71e-05	0.00067	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—SRD5A1—polycystic ovary syndrome	4.68e-05	0.000666	CbGpPWpGaD
Mebendazole—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	4.56e-05	0.000649	CbGpPWpGaD
Mebendazole—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	4.5e-05	0.00064	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—STAR—polycystic ovary syndrome	4.47e-05	0.000635	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	4.42e-05	0.000628	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	4.26e-05	0.000606	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	4.2e-05	0.000597	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	4.01e-05	0.000571	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—HMMR—polycystic ovary syndrome	3.98e-05	0.000566	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PNPLA2—polycystic ovary syndrome	3.95e-05	0.000561	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	3.9e-05	0.000555	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—HSD3B1—polycystic ovary syndrome	3.8e-05	0.00054	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	3.76e-05	0.000534	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—SRD5A1—polycystic ovary syndrome	3.74e-05	0.000532	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	3.67e-05	0.000522	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	3.67e-05	0.000522	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—STAR—polycystic ovary syndrome	3.57e-05	0.000507	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	3.57e-05	0.000507	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—LHB—polycystic ovary syndrome	3.46e-05	0.000493	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	3.41e-05	0.000485	CbGpPWpGaD
Mebendazole—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	3.4e-05	0.000484	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—HSD3B2—polycystic ovary syndrome	3.39e-05	0.000481	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—AKR1C1—polycystic ovary syndrome	3.28e-05	0.000466	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	3.19e-05	0.000454	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—HMMR—polycystic ovary syndrome	3.18e-05	0.000452	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—HSD3B1—polycystic ovary syndrome	3.03e-05	0.000431	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—SULT2A1—polycystic ovary syndrome	3.02e-05	0.000429	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	2.99e-05	0.000426	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—RRM2—polycystic ovary syndrome	2.92e-05	0.000416	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	2.9e-05	0.000413	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	2.9e-05	0.000413	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—YAP1—polycystic ovary syndrome	2.82e-05	0.000401	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—LHB—polycystic ovary syndrome	2.77e-05	0.000393	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—NAMPT—polycystic ovary syndrome	2.71e-05	0.000385	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—HSD3B2—polycystic ovary syndrome	2.7e-05	0.000385	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	2.69e-05	0.000383	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—CYP11A1—polycystic ovary syndrome	2.67e-05	0.00038	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	2.65e-05	0.000377	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—AKR1C1—polycystic ovary syndrome	2.62e-05	0.000372	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—AKR1C3—polycystic ovary syndrome	2.53e-05	0.000359	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—CYP17A1—polycystic ovary syndrome	2.49e-05	0.000353	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	2.43e-05	0.000346	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—SULT2A1—polycystic ovary syndrome	2.41e-05	0.000343	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—RRM2—polycystic ovary syndrome	2.33e-05	0.000332	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	2.31e-05	0.000328	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—YAP1—polycystic ovary syndrome	2.25e-05	0.00032	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	2.2e-05	0.000313	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—NAMPT—polycystic ovary syndrome	2.16e-05	0.000307	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—TH—polycystic ovary syndrome	2.15e-05	0.000306	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—CYP11A1—polycystic ovary syndrome	2.14e-05	0.000304	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—SLC2A4—polycystic ovary syndrome	2.09e-05	0.000297	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—AKR1C3—polycystic ovary syndrome	2.02e-05	0.000287	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—CYP17A1—polycystic ovary syndrome	1.99e-05	0.000282	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—CYP19A1—polycystic ovary syndrome	1.97e-05	0.00028	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	1.96e-05	0.000279	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	1.87e-05	0.000266	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—GNAS—polycystic ovary syndrome	1.76e-05	0.00025	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—TH—polycystic ovary syndrome	1.72e-05	0.000244	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	1.71e-05	0.000242	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—NCOR1—polycystic ovary syndrome	1.67e-05	0.000238	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—SLC2A4—polycystic ovary syndrome	1.67e-05	0.000238	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	1.67e-05	0.000237	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	1.61e-05	0.000229	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—CYP19A1—polycystic ovary syndrome	1.57e-05	0.000223	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	1.49e-05	0.000211	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—MTHFR—polycystic ovary syndrome	1.48e-05	0.00021	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	1.44e-05	0.000205	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—GNAS—polycystic ovary syndrome	1.4e-05	0.000199	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	1.39e-05	0.000197	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—NCOR1—polycystic ovary syndrome	1.34e-05	0.00019	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	1.33e-05	0.000189	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	1.32e-05	0.000187	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—CYP1A1—polycystic ovary syndrome	1.27e-05	0.00018	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	1.24e-05	0.000177	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	1.22e-05	0.000174	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PPARG—polycystic ovary syndrome	1.2e-05	0.00017	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—POMC—polycystic ovary syndrome	1.18e-05	0.000168	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—MTHFR—polycystic ovary syndrome	1.18e-05	0.000168	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—INS—polycystic ovary syndrome	1.18e-05	0.000167	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—TH—polycystic ovary syndrome	1.06e-05	0.00015	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	1.03e-05	0.000146	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	9.68e-06	0.000138	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PPARG—polycystic ovary syndrome	9.57e-06	0.000136	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—POMC—polycystic ovary syndrome	9.44e-06	0.000134	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—INS—polycystic ovary syndrome	9.39e-06	0.000133	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	8.64e-06	0.000123	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	8.23e-06	0.000117	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	7.8e-06	0.000111	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	7.27e-06	0.000103	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	5.9e-06	8.39e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	5.82e-06	8.27e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—INS—polycystic ovary syndrome	5.79e-06	8.22e-05	CbGpPWpGaD
